NCT04258904 is a NA clinical trial of Skin Care Program in Type 1 Diabetes, sponsored by Copenhagen University Hospital at Herlev.

Who is sponsoring NCT04258904?

NCT04258904 is sponsored by Copenhagen University Hospital at Herlev.

What drugs are being tested in NCT04258904?

Interventions in NCT04258904: Skin Care Program.

What condition does NCT04258904 study?

NCT04258904 studies Type 1 Diabetes, Dermatologic Complication.

Is NCT04258904 still recruiting?

NCT04258904 is currently completed. Last updated 7 December 2022.

Last reviewed 2022-12-07 · How we verify

NCT04258904

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevention of Skin Problems With Diabetes Devices in Pediatric Patients

Completed NA Last updated 7 December 2022

What this trial tests

NA trial testing Skin Care Program in Type 1 Diabetes in 236 participants. Completed in 30 November 2022.

Timeline

10 March 2020

Primary endpoint
20 September 2022

30 November 2022

Quick facts

Lead sponsor	Copenhagen University Hospital at Herlev
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	236
Start date	10 March 2020
Primary completion	20 September 2022
Estimated completion	30 November 2022
Sites	1 location across Denmark

Drugs / interventions tested

Skin Care Program

Conditions studied

Type 1 Diabetes — all drugs for Type 1 Diabetes →
Dermatologic Complication — all drugs for Dermatologic Complication →

Sponsor

Copenhagen University Hospital at Herlev

Who can join

Adults 2 to 20, any sex, with Type 1 Diabetes or Dermatologic Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A Cluster-controlled Intervention Trial regarding Prevention of Dermatological Complications towards use of Continuous glucose monitoring and insulin pumps in pediatric patients with Type 1 Diabetes. The patients will be followed prospectively with visits every 3rd month for the first year of initiation of device. Besides a standardized treatment plan if dermatological complications evolve, will be used.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Clinical Measurement of Transepidermal Water Loss.
Kundu D, Jayaraman A, Sen CK. · · 2026 · cited 4× · PMID 40476522 · DOI 10.1089/wound.2024.0148
Ultrasound Detected Subcutaneous Changes in a Pediatric Cohort After Initiation of a New Insulin Pump or Glucose Sensor.
Sørensen FMW, Svensson J, Kinnander C, Berg AK. · · 2023 · cited 2× · PMID 37279034 · DOI 10.1089/dia.2023.0137

Verify or expand the search:

Other recruiting trials for Type 1 Diabetes

Currently open trials in the same condition.

NCT07061574 — A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On · Phase 1, PHASE2 · recruiting
NCT07360080 — Long-Term Outcomes of Teplizumab in Routine Clinical Care · recruiting
NCT07457580 — Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs) · recruiting
NCT07212179 — Safety and Feasibility of a Self-Learning Bolus Calculator With Simplified Meal Announcement in Adolescents With Type 1 · NA · recruiting
NCT07287943 — To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes. · NA · recruiting

Other Copenhagen University Hospital at Herlev trials

Trials by the same sponsor.

NCT06802991 — Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0) · NA · recruiting
NCT06440616 — Benefit of Spectral Information in Patients Suspected for Lung Cancer · NA · recruiting
NCT06259279 — High Impact Training to Patients with Prostate Cancer and Bone Metastases · NA · recruiting
NCT06234306 — Molecularly Redefining Small Bowel Adenocarcinoma to Accelerate Precision Patient Care · recruiting
NCT06089551 — Early vs Postponed Parenteral Nutrition After Emergency Abdominal Surgery · Phase 4 · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04258904 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Copenhagen University Hospital at Herlev
Last refreshed: 7 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04258904.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing